AzTrials
AzTrials

Obsessive-Compulsive DisorderCTOCDNCT02818088

Cognitive Training in Obsessive Compulsive Disorder

A study testing n-Back (Cognitive Training) in people with Obsessive-Compulsive Disorder, run by University of Stellenbosch at 1 site in South Africa.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This unique study will allow us to observe the neural correlates associated with working memory in an obsessive compulsive disorder (OCD) paradigm. We believe that developing working memory in participants suffering with OCD will reduce the severity of their symptomology. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Obsessive-Compulsive Disorder
What is being tested?
n-Back (Cognitive Training)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
9 participants
Where
1 siteSouth Africa
Study dates
Feb 2016to Dec 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • A primary diagnosis of OCD, with a score > 16 on the Yale-Brown Obsessive Compulsive Scale (YBOCS) (Goodman et al, 1989b, 1006-1011).
  • Participants must be aged older than 18 and younger than 65 years.
  • Right handed.
  • If taking SSRI's the participant needs to be on a stable dose for at least 2 months.

Who cannot join

  • Significant physical or neurological illnesses. An exception will be made for patients taking SSRI's (and not using any other drugs).
  • Any significant current DSM disorder (in addition to OCD).
  • Past history of significant substance or alcohol abuse.
  • Pregnancy.
  • Any metal pins/ prostheses or cardiac pacemakers.
  • Sufferers of claustrophobia.
  • Head injury

Trial locations and contacts

1 site in 1 country.

South Africa1 site
  • Stellenbosch University

    Cape Town, Western Cape, 7505

Other trials in South Africa

About this study

Official title: Cognitive Training in Patients With Obsessive Compulsive Disorder

This unique study will allow us to observe the neural correlates associated with working memory in an obsessive compulsive disorder (OCD) paradigm. We believe that developing working memory in participants suffering with OCD will reduce the severity of their symptomology. This will allow a greater understanding into the functioning of these participants which in turn presents with treatment possibilities.

Read the detailed description

It is currently unclear whether cognitive training using a working memory task, is effective in reducing obsessive-compulsive symptoms and neuropsychological deficits in patients with OCD. Two groups (OCD and control) will be recruited. Both groups will undergo an intervention consisting of 8 weeks of cognitive training. Working memory, neuropsychological functioning and OCD symptomatology will be assessed pre and post-treatment, in both groups. Furthermore neuroimaging using functional magnetic resonance imaging (fMRI) will be conducted at baseline as well as at the end of the 8 week period in both groups. The scan will serve to show any structural or functional changes in the frontostriatal area involved with working memory. To our knowledge, this is one of the first studies to date to examine whether cognitive training improves symptoms in OCD.

Being tested
n-Back (Cognitive Training)
Medical subject headings
Obsessive-Compulsive Disorder

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • n-Back (Cognitive Training)Behavioural

Study groups in NCT02818088
Study groupRoleWhat they receive
Cognitive TrainingExperimentalCognitive Training - n Back.
Receives: Behavioral: n-Back (Cognitive Training)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Yale-Brown Obsessive Compulsive Scale (YBOCS)

    Measured: Immediately after intervention

  2. Cambridge neuropsychological test automated battery (CANTAB)

    Measured: Immediately after intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted29 Jun 2016 (estimated)
  2. Study startFeb 2016
  3. Primary completionDec 2019
  4. Study completionDec 2019

Why it stopped: The app platform was cancelled and key personnel withdrew from the project

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
9 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02818088
Sponsor's protocol ID
S14/05/113
Acronym
CTOCD
Status last verified
May 2021
First submitted
27 Jun 2016
Last updated
6 May 2021
Results posted
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing n-Back (Cognitive Training) in people with Obsessive-Compulsive Disorder, run by University of Stellenbosch at 1 site in South Africa.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 6 May 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Africa. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: The app platform was cancelled and key personnel withdrew from the project). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Yale-Brown Obsessive Compulsive Scale (YBOCS) (time frame: Immediately after intervention). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 May 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in